Atlas Trials

Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions

Clinical trial NCT06132243 · COMPLETED

Trial details

NCT number
NCT06132243
Sponsor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelofibrosis
Start date
2023-11-29
Primary completion
2023-12-20
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.